ETHEL OBIOHA: Open Payments
NPI 1518592690 · MISSOURI CITY, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$459 in 17 payments from 8 companies in 2025. Trend: 2023 $636 · 2024 $1,047 · 2025 $459
Food & beverage: $459
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. | 2 | $146 |
| Novo Nordisk Inc | 4 | $95 |
| AstraZeneca Pharmaceuticals LP | 3 | $57 |
| Inspire Medical Systems, Inc. | 2 | $43 |
| Dexcom, Inc. | 2 | $40 |
| Exact Sciences Corporation | 2 | $39 |
| Smith+Nephew, Inc. | 1 | $24 |
| Amgen Inc. | 1 | $15 |
Products named: Livdelzi, Ozempic, INSPIRE, Dexcom G6 Transmitter, Cologuard Collection Kit, FARXIGA, STRAVIX PL, BREZTRI.
Industry payments across TX — which companies pay providers there.
